BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Macquarie maintains outperform on Apollo Hospitals
Pharmacy business valued at 2-times FY'15 enterprise value/sales. Balance sheet provides lever for future expansions. Pharma margin expansion is the trigger to watch. Target at Rs 1190.